Systemic adjuvant therapy for adult patients at high risk for recurrent cutaneous or mucosal melanoma: an Ontario Health (Cancer Care Ontario) clinical practice guideline.

Petrella, T M; Fletcher, G G; Knight, G; McWhirter, E; Rajagopal, S; Song, X; Baetz, T D

Petrella, T M; Fletcher, G G; Knight, G; McWhirter, E; Rajagopal, S; Song, X; Baetz, T D.

Affiliation

Petrella TM; University of Toronto and Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON.
Fletcher GG; Program in Evidence-Based Care, Ontario Health (Cancer Care Ontario), and Department of Oncology, McMaster University, Hamilton, ON.
Knight G; Department of Oncology, McMaster University, Hamilton, and Grand River Regional Cancer Centre, Kitchener, ON.
McWhirter E; Department of Oncology, Division of Medical Oncology, McMaster University, and Juravinski Cancer Centre, Hamilton, ON.
Rajagopal S; Credit Valley Hospital, Mississauga, ON.
Song X; Department of Internal Medicine, Division of Medical Oncology, University of Ottawa, and The Ottawa Hospital Cancer Centre, Ottawa, ON.
Baetz TD; Department of Oncology, Queen's University, and Cancer Centre of Southeastern Ontario-Kingston General Hospital, Kingston, ON.

Curr Oncol ; 27(1): e43-e52, 2020 02.

Article de En | MEDLINE | ID: mdl-32218667

Sujet(s)
Mots clés

Melanoma; adjuvant therapy; immune checkpoint inhibitors; interferon; practice guidelines; targeted therapy

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs cutanées / Traitement médicamenteux adjuvant / Mélanome Type d'étude: Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limites: Female / Humans / Male Pays/Région comme sujet: America do norte Langue: En Journal: Curr Oncol Année: 2020 Type de document: Article

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google